RoxyBond is the first and only immediate-release opioid medication with FDA-approved labeling describing abuse-deterrent properties.1 PRINCETON, N.J., July 06, 2022…
Mr. Larsen brings over 40 years of medical device industry experience and skills strongly aligned with the Company’s strategy to…
BELTSVILLE, Md., July 06, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel,…
- Phase 3 Clinical Study Met Primary and Key Secondary Endpoints - - Primary Endpoint: Sabizabulin Treatment Showed Statistically Significant…
TORONTO, July 06, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),…
ACTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a medical diagnostics company…
Second Quarter Revenue of $2.9 Million, Year-Over-Year Increase of 27%;Number of Active Customer Sites Climbs 21% Year-Over-Year SOUTH ORANGE, NJ,…
Topline results anticipated fourth quarter of 2022BRISBANE, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a…
For Every Two Boxes of SilverSeal® Purchased, One is Donated to Those Suffering in Ukraine LANGHORNE, Pa., July 06, 2022…
Appointments named for two key executive leadership positions in human resources and translational medicineSOUTH SAN FRANCISCO, Calif., July 06, 2022…